(R)-3-Cyclopentyl-3-Hydrazinylpropanenitrile L-Tartaric Acid Salt Dihydrate: A Vital Pharmaceutical Building Block
Discover the essential intermediate powering cutting-edge pharmaceutical development. High purity and certified quality.
Get a Quote & SampleProduct Core Value
(R)-3-Cyclopentyl-3-Hydrazinylpropanenitrile L-Tartaric Acid Salt Dihydrate
This high-quality pharmaceutical intermediate is a critical component in the synthesis of advanced active pharmaceutical ingredients (APIs), notably Ruxolitinib Phosphate. Its precise chemical structure and confirmed purity levels ensure reliability and efficiency in complex manufacturing processes, supporting the development of vital medicines.
- Explore the critical role of this pharmaceutical intermediate in Ruxolitinib Phosphate production, a key long-term survival benefit contributor.
- Source CAS 2761879-36-9 from reliable China pharmaceutical chemical suppliers to ensure process efficiency.
- Learn about the synthesis of (R)-3-Cyclopentyl-3-Hydrazinylpropanenitrile L-Tartaric Acid Salt Dihydrate and its applications in advanced pharmaceutical synthesis.
- Benefit from high purity (>98%) and certifications like GMP and ISO 9001 when you buy Ruxolitinib Phosphate intermediate.
Key Advantages
Assured Purity and Quality
With a purity exceeding 98% and certifications including GMP and ISO 9001, this intermediate guarantees consistent results in your API synthesis, essential for buy Ruxolitinib Phosphate intermediate campaigns.
Critical for Ruxolitinib Synthesis
Serves as a foundational element in the Ruxolitinib Phosphate production, a drug known for its role in managing myeloproliferative neoplasms and improving patient survival.
Supply Chain Reliability
Access a stable supply from China pharmaceutical chemical suppliers, ensuring your manufacturing schedules are met without disruption.
Key Applications
Pharmaceutical Synthesis
Essential for the multi-step synthesis of complex APIs, leveraging its specific chemical structure for targeted reactions and high yields.
Ruxolitinib Production
A direct precursor in the manufacturing of Ruxolitinib Phosphate, a vital treatment for specific hematological disorders, impacting long-term survival.
Scientific Research
Utilized in laboratories for research and development in new drug discovery and process optimization, aiding in advanced pharmaceutical synthesis.
Health Sector Support
Contributes to the broader health sector by providing a necessary building block for life-saving medications, supporting campaigns to buy Ruxolitinib Phosphate intermediate.